LDS/Medical Tests/Antimicrobial Susceptibility, AFB/Mycobacteria

Antimicrobial Susceptibility, AFB/Mycobacteria

MIC (Mmínimum Inhibitory Concentration) is the minimal concentration of an antibacterial agent that is able to prevent the visible growth of the tested bacteria. MIC tests are usually performed to predict the effectiveness of the tested agent. This information is helpful for clinicians to select the best antibiotic(s) for bacterial infections with one or more species.

Broth microdilution is currently the most commonly used method to determine MIC. A microtiter tray containing a variety of antimicrobial agents at different concentrations is inoculated a single strain of bacteria from culture plates. After a certain period of incubation, growth of bacteria is determined by turbidity of culture broth or colony-like bacteria growth at the bottom of the well. The lowest concentration without visible bacterial growth is the MIC. Automated or semi-automated MIC testing is available on most automated bacterial identification systems.

MIC is usually reported in microgram/mL (µg/mL). MIC value is then compared to the interpretive threshold (breakpoints) established by Clinical and Laboratory Standards Institute (CLSI). The breakpoints list covers common pathogens and antibacterial agents and the threshold is determined based on pharmacokinetic/pharmacodynamic data and clinical studies. If the MIC value is less than or equal to the susceptible breakpoint, the tested bacteria should be inhibited with recommended dosage (Susceptible); if the MIC value is equal to or greater than the resistant breakpoint, the tested bacteria may not be inhibited to the tested antibacterial agent (Resistant); if the MIC value is between the susceptible breakpoint and resistant breakpoint, the antibiotic agent tested may require higher or more frequent dosage (Susceptible-Dose Dépendent (SDD)) or have lower response rates than susceptible isolates (Intermediate).

Interpretation of MIC data is based on attainable concentrations in specific body sites/fluids. Other factors should also be considered, including route of administration, age and weight of the patient, state of health of the patient, etc.

It may not be possible to perform MIC testing for organisms with special nutrient or culture requirements, when there are no published CLSI interpretive criteria, when the drug is not available on the MIC test platform being used or when a drug is known to be ineffective regardless of the in vitro results.

  • As an aid in the diagnosis of bacterial infections
  • Assist in treatment selection; antibiotic selection

Susceptible (S): The standard dose will likely work against this organism.

Susceptible-Dose Dependent (SDD): The drug can work, but only at a higher dose or more frequent dosing than the standard regimen. Check the drug label for proper dosing.

Intermediate (I): The drug may still work, but success is less certain than "Susceptible." Also acts as a buffer zone to absorb minor testing variability, especially for drugs with a narrow safety margin.

Resistant (R): The standard dose is unlikely to work — either the drug can't reach effective levels, resistance mechanisms are likely present, or clinical studies haven't shown reliable efficacy.

Nonsusceptible: Used when no resistant strains have been identified for this organism/drug combo (so no "R" category exists). If the MIC is above the susceptible breakpoint, it's reported as nonsusceptible rather than resistant.

Susceptible

Agar or broth dilution. Most common automated instrumentation Vitek, Microscan, Phoenix and etc.).

Pure isolate of aerobic bacteria in transport media or on agar. Mixed culture or culture that is not actively growing cannot be tested.

Transport specimen at room temperature according to appropriate infectious agent shipping guidelines.

Susceptibility Testing of Anaerobic Bacteria; Antimicrobial Susceptibility, Nocardia species; Inducible clindamycin resistance; β-lactamase; ESBL ; MHT; Carba NP ; MRSA Agar; Vancomycin agar screen; HLAR by disk diffusion.
3-8 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Biosens Bioelectron. 2019 Oct 1;142:111552. [PMID: 31421358]
  • PLoS One. 2016 May 18;11(5):e0155599. [PMID: 27191612]
  • Biotechnol Lett. 2019 Feb;41(2):221-230. [PMID: 30542946]
  • Diagnostics (Basel). 2019 May 3;9(2). [PMID: 31058811]
  • Bailey & Scott’s Diagnostic Microbiology, 14th edition Laboratory Diagnosis of Infectious Diseases: Essentials of Diagnostic Microbiology 1st Edition
  • CLINICAL MICROBIOLOGY REVIEWS, July 2007, Vol. 20, No. p. 391–408
  • CLSI Performance Standards for Antimicrobial Susceptibility Testing, 29th Edition